The states largest health insurer on Friday reported it had an operating loss of $380.5 million for 2025, second only to the year before
The dose challenge
3 To put those figures in practical terms: a person starting at 100kg who adhered fully to treatment would, on average, lose around 16.6kg over 64 weeks
In a separate study involving 190 patients receiving 52 weeks of treatment, remission rates were 36.8%, 45.6%, and 52.0% for the 5, 10, and 15 mg tirzepatide groups, respectively, compared to 18.2% in the placebo group (Nevola et al., 2023)
387 Pegloticase, a recombinant urate oxidase conjugated to polyethylene glycol (PEG), has been introduced to reduce immunogenicity and extend the half-life of rasburicase